Global Gene Editing Technology Market Growth (Status and Outlook) 2024-2030

Global Gene Editing Technology Market Growth (Status and Outlook) 2024-2030

According to this study, the global Gene Editing Technology market size will reach US$ million by 2030.

Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.

Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.

Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Technology market by product type, application, key players and key regions and countries.

Segmentation by product type:
Homologous Recombination
Meganuclease

Segmentation by Application:
Agriculture
Medical
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV

Please note: The report will take approximately 2 business days to prepare and deliver.